Pharmacology of the urotensin-II receptor antagonist palosuran (ACT-058362; 1-[2-(4-benzyl-4-hydroxy-piperidin-1-yl)-ethyl]-3-(2-methyl-quinolin-4-yl)-urea sulfate salt): first demonstration of a pathophysiological role of the urotensin System
about
The role of urotensin II in cardiovascular and renal physiology and diseasesBiochemical and functional characterization of high-affinity urotensin II receptors in rat cortical astrocytesThe Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptorsThe relationship between urotensin II and its receptor and the clinicopathological parameters of breast cancer.GSK1562590, a slowly dissociating urotensin-II receptor antagonist, exhibits prolonged pharmacodynamic activity ex vivoDown-regulation of GABA(A) receptor via promiscuity with the vasoactive peptide urotensin II receptor. Potential involvement in astrocyte plasticityIn vitro and in vivo pharmacological characterization of the novel UT receptor ligand [Pen5,DTrp7,Dab8]urotensin II(4-11) (UFP-803)The peptidic urotensin-II receptor ligand GSK248451 possesses less intrinsic activity than the low-efficacy partial agonists SB-710411 and urantide in native mammalian tissues and recombinant cell systemsPotential Clinical Implications of the Urotensin II Receptor Antagonists.Regional heterogeneity in the haemodynamic responses to urotensin II infusion in relation to UT receptor localisationPopulation pharmacodynamic modeling of hyperglycemic clamp and meal tolerance tests in patients with type 2 diabetes mellitus.Urotensin II in cardiovascular regulation.Effect of the urotensin-II receptor antagonist palosuran on secretion of and sensitivity to insulin in patients with Type 2 diabetes mellitus.Role of urotensin II in health and disease.Emerging drugs for managing kidney disease in patients with diabetes.Urotensin-II Ligands: An Overview from Peptide to Nonpeptide StructuresPalosuran treatment effective as bosentan in the treatment model of pulmonary arterial hypertension.Diabetes-induced upregulation of urotensin II and its receptor plays an important role in TGF-beta1-mediated renal fibrosis and dysfunction.Palosuran inhibits binding to primate UT receptors in cell membranes but demonstrates differential activity in intact cells and vascular tissues.Nonpeptidic urotensin-II receptor antagonists I: in vitro pharmacological characterization of SB-706375.Update on the urotensinergic system: new trends in receptor localization, activation, and drug designPrediction of the three-dimensional structure for the rat urotensin II receptor, and comparison of the antagonist binding sites and binding selectivity between human and rat receptors from atomistic simulations.The vasoactive peptides urotensin II and urotensin II-related peptide regulate astrocyte activity through common and distinct mechanisms: involvement in cell proliferation.Urotensin-II contributes to pulmonary vasoconstriction in a perinatal model of persistent pulmonary hypertension of the newborn secondary to meconium aspiration syndrome.Pharmacokinetics and pharmacodynamics of the urotensin-II receptor antagonist palosuran in healthy male subjects.Predicted ligands for the human urotensin-II G protein-coupled receptor with some experimental validation.Renal effects of human urotensin-II in rats with experimental congestive heart failure.Potent cardiovascular effects of homologous urotensin II (UII)-related peptide and UII in unanesthetized eels after peripheral and central injections.Can early myocardial infarction-related deaths be diagnosed using postmortem urotensin receptor expression levels?
P2860
Q24675590-6C3BD7D4-AE1B-4B62-8D02-4C466752AC98Q28260943-2257BED9-82A1-4198-8176-876079A468A4Q30486707-3A621D92-B41D-4787-B993-E938B960F64AQ34066190-BE39B981-D2FF-47A1-9559-ACE551B919EBQ34233981-5BA546A6-5633-4C39-9F92-6157597E545DQ34260110-461AF06D-BA1A-463E-8BF8-93C00A6C2B84Q35098581-94D14E93-21B6-4487-9D47-5BFD4C809C86Q35100902-883364D8-E628-4408-B33A-0762FFBCCF04Q35128456-A3CDB9EE-5F12-43CA-875B-291BD4D368B8Q35545386-B11F2CDE-46DA-4D96-B70A-75C5D6F4B2CBQ37207848-1A72E44E-0CAE-4B28-BBB5-02B0BC9A9B5AQ37344439-FFD2C5A2-B2CE-4B18-BDF7-A20D1BA7E19CQ37427914-2D830F90-147D-4A7D-8E0B-3E2C06284656Q37737495-10D7473E-473B-4A6D-8C45-B3D217DBEEDEQ38075029-2D462672-1642-49A2-B343-EFC40DD8F41FQ38093584-398D1F8E-183D-4FA2-881C-D3B0F2C2732EQ39236752-E0843CCB-48F6-46D9-BE8A-F57FDDE789D7Q39939179-C42DFCA5-52DD-4D40-85CF-A50A03D3C15AQ39967100-49DEFB5D-A626-4DE2-A9D6-9371F1849792Q40430686-8F41206F-DC90-435F-BECF-F9907465028EQ41767436-0F8B2FD2-94FC-45BF-BFAE-281A1549A1EAQ42397196-3183967D-884B-4236-96BC-7C56A9EB34C1Q43146165-B49EDC18-0DD7-4290-B0EE-E0D06007794AQ43266046-0F1D2672-63B5-4BA2-9CCF-DC6625511CD8Q45922685-3429E5DE-90B8-4931-B85E-D06B23769F64Q46248274-D47FECB8-6FAF-4C9E-9D4B-9FB3D381BFC7Q46882457-EC9296A2-D549-4EC6-99E8-3C5D805624C3Q48061365-B37350C0-25B4-4180-A0B6-CF15162667A8Q54202541-A2173B89-89A5-40E3-8D15-FE90F3ACB2DE
P2860
Pharmacology of the urotensin-II receptor antagonist palosuran (ACT-058362; 1-[2-(4-benzyl-4-hydroxy-piperidin-1-yl)-ethyl]-3-(2-methyl-quinolin-4-yl)-urea sulfate salt): first demonstration of a pathophysiological role of the urotensin System
description
2004 nî lūn-bûn
@nan
2004 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
name
Pharmacology of the urotensin- ...... l role of the urotensin System
@ast
Pharmacology of the urotensin- ...... l role of the urotensin System
@en
Pharmacology of the urotensin- ...... l role of the urotensin System
@nl
type
label
Pharmacology of the urotensin- ...... l role of the urotensin System
@ast
Pharmacology of the urotensin- ...... l role of the urotensin System
@en
Pharmacology of the urotensin- ...... l role of the urotensin System
@nl
prefLabel
Pharmacology of the urotensin- ...... l role of the urotensin System
@ast
Pharmacology of the urotensin- ...... l role of the urotensin System
@en
Pharmacology of the urotensin- ...... l role of the urotensin System
@nl
P2093
P356
P1476
Pharmacology of the urotensin- ...... l role of the urotensin System
@en
P2093
Boris Mathys
Celia Müller
Changbin Qiu
Christoph Binkert
Claus Müller
Céline Boukhadra
Jian-Fei Xi
Jörg Velker
Keith Morrison
Magdalena Birker-Robaczewska
P304
P356
10.1124/JPET.104.068320
P407
P577
2004-10-01T00:00:00Z